d0ad941a-d360-47ab-8fb1-df2c3d085994 (Collection)

Id Namespace:

4D Nucleome

Identifier Namespace (Entity type)

Dcc Asset:

250924 c2m2 4dn sub.zip

Processed File (Entity type)

Dcc:

4DN

DCC (Entity type)

Persistent Id:https://data.4dnucleome.org/4DNESR61Z21Z

Description:4DNESR61Z21Z: TSA-seq v2 THRAP3 in HCT116 SON SRRM2 double degron cells - condition3primeenhancementG-anti-THRAP3_Auxin Set of Inputs for Replicates of THRAP3 TSA-seq version 2 Reaction Condition 3' (PBS 50% Sucrose plus 1.5 mM DTT) 30 minute Reaction on Auxin treated HCT116 SON SRRM2 double degron cells

Creation Time:2025-08-27T00:00:00

Abbreviation:4DNESR61Z21Z

Results found

Linked to

	Label	Description
	393880ea-f928-406d-a4bf-78435b8975ef Subject (Entity type)	A subject from 4DN produced as part of the ef637c2d 7e48 4e26 aad2 eac1f680d4e8 project
	ef637c2d-7e48-4e26-aad2-eac1f680d4e8 Project (Entity type)	IDENTIFICATION OF THE ACTIVE NUCLEAR NICHE(S) USING NOVEL PROTEOMIC, GENOMIC, TRANSGENIC, AND LIVE-C...
	55947dc8-e0f0-4cdb-b246-7c02b8b44b7b Collection (Entity type)	Biological replicate 1, Technical replicate 1 of 4DNESR61Z21Z
	da0bcadb-aea6-44dd-ad16-da4eb2079875 Collection (Entity type)	Biological replicate 2, Technical replicate 1 of 4DNESR61Z21Z

393880ea-f928-406d-a4bf-78435b8975ef

Subject (Entity type)

A subject from 4DN produced as part of the ef637c2d 7e48 4e26 aad2 eac1f680d4e8 project

ef637c2d-7e48-4e26-aad2-eac1f680d4e8

Project (Entity type)

IDENTIFICATION OF THE ACTIVE NUCLEAR NICHE(S) USING NOVEL PROTEOMIC, GENOMIC, TRANSGENIC, AND LIVE-C...

55947dc8-e0f0-4cdb-b246-7c02b8b44b7b

Collection (Entity type)

Biological replicate 1, Technical replicate 1 of 4DNESR61Z21Z

da0bcadb-aea6-44dd-ad16-da4eb2079875

Collection (Entity type)

Biological replicate 2, Technical replicate 1 of 4DNESR61Z21Z

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.